Refine by
Oncology Therapy Equipment & Supplies
19 equipment items found
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
Targeted therapies are revolutionizing oncology. Patients with chronic myeloid leukemia treated with the tyrosine kinase inhibitors (TKI) now have life expectancies approaching that of the general population. Imatinib (Gleevec®, Gilvec®) the first TKI approved has substantial efficacy in chronic myeloid leukemia (CML) and gastrointestinal stromal ...
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
Neutropenia and neuropathy can be serious side-effects associated with paclitaxel chemotherapy. While hematological toxicities can be addressed, there is no good solution for chemotherapy induced peripheral neuropathy, which is frequent, may be debilitating and can persist or appear after ...
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
BSA dosing results in sub-target 5-FU levels in the majority of patients. PK- guided dosing can move 5-FU levels into the target range. Optimal dosing of 5-FU is associated with increased efficacy and reduced ...
by:Evaxion Biotech A/S based inHørsholm, DENMARK
PIONEER is our proprietary AI platform for the rapid discovery and design of patient-specific neoepitopes used to derive immuno-oncology therapies. It has been shown that neoepitopes, which arise from patient-specific tumor mutations, play a critical role in T-cell mediated antitumor immune ...
Manufactured by:Medcaptain Medical Technology Co., Ltd. based inShenzhen City, CHINA
Open system for universal IV sets Applicable for blood transfusion, nutrition support and oncology ...
Manufactured by:Gilead based inFoster City, CALIFORNIA (USA)
Sacituzumab govitecan-hziy 180 mg for injection. ...
Manufactured by:Gilead based inFoster City, CALIFORNIA (USA)
Brexucabtagene autoleucel . TECARTUS.TECARTUS®(brexucabtagene autoleucel)suspension for intravenous infusion. ...
Manufactured by:Philips Healthcare based inAmsterdam, NETHERLANDS
Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution . With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage ...
Manufactured by:Cerbios-Pharma SA based inBarbengo – Lugano, SWITZERLAND
For over 40 years, Cerbios has been a worldwide market leader for the manufacture and supply of reduced Folates. Folates are a class of water soluble compounds belonging to the Vitamin B complex which are essential for a number of metabolic functions, including processes involved in the development and metabolism of CNS and the production of DNA and RNA, primarily in infancy, adolescence and ...
Manufactured by:Keller Technology Corporation (KTC) based inTonawanda, NEW YORK (USA)
Keller provides medical device and equipment manufacturing for imaging and radio oncology including proton therapy, linac delivered radiotherapy, PET and MRI. We bring expertise in cGMP regulatory environments. Projects include accelerator, cyclotron and magnet-based equipment for imaging or therapeutic ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
It is the only bevacizumab with metastatic colorectal cancer Phase III clinical data in China and proposed to be combined with HANSIZHUANG (PD-1) for immuno-oncology combination therapies to treat various ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC is using antibodies and antibody fragments attached to lipid encapsulated drugs to develop more effective therapies in oncology. These antibody-linked nanomedicines actively target specific tissues using binding interactions between a specific antibody and a target antigen on the surface of a particular cell type. Compared with passively targeted ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
(serplulimab injection, anti-PD-1 mAb), company’s first self-developed innovative monoclonal antibody, was approved by the NMPA for the treatment of Microsatellite Instability-High (MSI-H) solid tumors in March 2022, providing an alternative treatment option for patients with MSI-H solid tumors. Henlius actively promotes HANSIZHUANG in conjunction with in-house products of the company and ...
Manufactured by:Lupagen Inc. based inDallas, TEXAS (USA)
Lupagen avoids the cost & complexity of cell therapy and the safety & clinical challenges of viral-based gene therapy by a simple patient-connected gene delivery procedure done at the bedside. Our Side CAR-T® delivery system, a first-in-class bedside system enables gene delivery directly to target cells in a highly-controlled and safe environment before reinfusing therapies to the ...
Manufactured by:INTERmedic Arfran based inBarcelona, SPAIN
INTERmedic, worldwide leader in photodynamic therapy for pulmonology (lung cancer), gastroenterology (Barrett’s esophagus, esophageal cancer), urology (prostate cancer) among others, presents Multidiode™ PDT, an innovative technology to treat dermatological pathologies such as basal cell carcinoma, cholangiocarcinoma or hidradenitis ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
Leukopaks are enriched leukapheresis products collected from healthy and consenting donors using the Spectra Optia® Apheresis System following an IRB-approved protocol. Leukopaks typically contain up to 50% T cells, 20% monocytes, 10% B cells, 10% NK cells, 3% granulocytes, and 3% hematocrit. Leukapheresis results in high yields of single-donor mononuclear cells (MNCs) compared to ...
Manufactured by:CanVirex AG based inBasel, SWITZERLAND
Oncolytic measles viruses as a multiplexed immune-modulating platform for cancer therapy. Cancer remains a medical and social burden worldwide despite several technological advances in the past decades. Conventional cancer treatments such as surgery, chemo-, or radiotherapy are restricted to local therapy or by dose-limiting toxicities and may induce drug resistance during treatment. In recent ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
Hematopoietic stem and progenitor cells (HSPCs) are the key stem cell population in the bone marrow capable of self-renewal and multilineage differentiation into mature blood cell types. CD34+ HSPCs can be isolated from mobilized peripheral blood, bone marrow, and umbilical cord blood. Clinical HSPC transplantation is used to treat blood cancers (leukemia, myeloma and lymphomas), autoimmune ...